Login
$CYPH
$1.92 -$0.01 (0.26%) After hours

$CYPH 8-K SEC Filings

Filed On Filing
16 Nov 2026 8-K: Results of Operations and Financial Condition

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

22 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of September __, 2026 between Cypherpunk Technologies Inc., a Delaware corporation (the “Company”), and the person whose name appears on the signature page here...

02 Sep 2026 8-K: Other Events

As previously disclosed, on July 20, 2026, Cypherpunk Technologies Inc. (the “Company”) received a notification letter from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because th...

18 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of August 17, 2026, is entered into by and among MORIA MINING, LLC, a Delaware limited liability company (“Seller”), and WINKLEVOSS TREASURY INVESTMENTS, LLC, a Delaware limited ...

12 Aug 2026 8-K: Results of Operations and Financial Condition; Other Events

Cambridge, Mass. – August 12, 2026 – Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026.

21 Jul 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On July 20, 2026, Cypherpunk Technologies Inc. (the “Company”) received a notification letter (the “Closing Bid Price Deficiency Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Compa...

22 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

(a) Cypherpunk Technologies Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on June 18, 2026.

26 May 2026 8-K: Other Events

As previously reported, on March 4, 2026, Cypherpunk Technologies Inc. (the “Company”) received a notification letter (the “Closing Bid Price Deficiency Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasd...

14 May 2026 8-K: Results of Operations and Financial Condition

Cambridge, MA – May 14, 2026 – Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026.

10 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 7, 2026, Dr. Christopher Mirabelli and Dr. Joseph Loscalzo, members of the Board of Directors (the “Board”) of Cypherpunk Technologies Inc. (the “Company”), each notified the Company of his intent to retire as a member of the Bo...

16 Mar 2026 8-K: Results of Operations and Financial Condition

Cambridge, MA – March 16, 2026 – Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the year ended December 31, 2025.

09 Mar 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On March 4, 2026, Cypherpunk Technologies Inc. (the “Company”) received a notification letter (the “Closing Bid Price Deficiency Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Compa...

30 Dec 2025 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement

This RESTRICTED STOCK UNIT GRANT AGREEMENT (the “Agreement”), dated as of December 23rd, 2025 (the “Date of Grant”), is delivered by Cypherpunk Technologies Inc. (formerly known as Leap Therapeutics, Inc.) (the “Company”) to CoinXit Ltd ...

30 Dec 2025 8-K: Regulation FD Disclosure; Other Events

Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC

16 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +2 more

This Plan is intended to provide incentives that will attract, retain and motive highly competent officers, directors, employees, consultants and advisors to promote the success of the Company’s business and align employees’ interests wi...

20 Nov 2025 8-K: Entry into a Material Definitive Agreement

This WAIVER AND MODIFICATION AGREEMENT (this “Agreement”) is made and entered into as of November 19, 2025, by and between Cypherpunk Technologies Inc. (f/k/a Leap Therapeutics, Inc.), a Delaware corporation (the “Corporation”), and Wink...

18 Nov 2025 8-K: Regulation FD Disclosure; Other Events

Cambridge, Mass., November 18, 2025 – Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced the company has purchased an additional 29,869.29 ZEC for $18 million, at an average purchase price of $602.63 per ZEC. The company recentl...

12 Nov 2025 8-K: Entry into a Material Definitive Agreement

Cypherpunk Technologies Inc. (f/k/a Leap Therapeutics, Inc.), a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

12 Nov 2025 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +4 more

The registered office of Leap Therapeutics,Cypherpunk Technologies Inc. (the “Corporation”) shall be fixed in the Corporation’s certificate of incorporation, as the same may be amended or restated from time to time (the “Certificate of I...

20 Oct 2025 8-K: Other Events

Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high population

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support